Managed Care Pharmacists Embrace AI, Fret About GLP-1 ‘Hyperutilization’
-
Mar 27, 2025
New uses for GLP-1 drugs, the proliferation of artificial intelligence (AI), and federal and state regulatory changes are among the top issues for managed care pharmacy over the next five years, according to a study from the Academy of Managed Care Pharmacy (AMCP).
“Anything that can replace manual tasks to allow the pharmacist to practice to the level of their license with their skill set and counsel patients on their medications and really work with them [is a plus],” AMCP Foundation Executive Director Mitzi Wasik tells AIS Health, a division of MMIT. AI “has really taken some of the manual burden off of the pharmacist. They are really trained to practice at a high skill set of patient care. A lot of times in the community setting, they just don’t have the capacity to do it.”
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.